(VIANEWS) – Meta Platforms (META), Erie Indemnity Company (ERIE), ICON plc (ICLR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Meta Platforms (META)
12.6% sales growth and 17.36% return on equity
Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. Meta Platforms, Inc. was incorporated in 2004 and is headquartered in Menlo Park, California.
Earnings Per Share
As for profitability, Meta Platforms has a trailing twelve months EPS of $8.55.
PE Ratio
Meta Platforms has a trailing twelve months price to earnings ratio of 35.65. Meaning, the purchaser of the share is investing $35.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.36%.
Previous days news about Meta Platforms(META)
- According to MarketWatch on Monday, 11 September, "Those potential gains, however, will largely depend on results from Amazon.com Inc. , Meta Platforms Inc. and Alphabet Inc. – outsized companies with outsized influence on markets and S&P 500 company financials overall. "
- According to MarketWatch on Monday, 11 September, "The Magnificent Seven are Apple Inc. , Microsoft Corp. , Nvidia Corp. , Amazon.com Inc. , Alphabet Inc. , Tesla Inc. and Meta Platforms Inc. . "
- According to MarketWatch on Monday, 11 September, "The Magnificent Seven are Apple Inc. , Microsoft Corp. , Nvidia Corp. , Amazon.com Inc. , Alphabet Inc. , Tesla Inc. and Meta Platforms Inc. . "
- According to MarketWatch on Monday, 11 September, "They also open the floodgates on tech conference season, with shows stacked up over the next several weeks for Facebook parent Meta Platforms Inc. , Microsoft Corp. , and Oracle Corp. ."
2. Erie Indemnity Company (ERIE)
10.3% sales growth and 24.54% return on equity
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $6.77.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 40.83. Meaning, the purchaser of the share is investing $40.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.54%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.7%, now sitting on 3.03B for the twelve trailing months.
Sales Growth
Erie Indemnity Company’s sales growth is 12% for the ongoing quarter and 10.3% for the next.
Yearly Top and Bottom Value
Erie Indemnity Company’s stock is valued at $276.42 at 20:22 EST, below its 52-week high of $293.26 and way above its 52-week low of $199.49.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 27.3% and 29.6%, respectively.
3. ICON plc (ICLR)
6.7% sales growth and 6.02% return on equity
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company's clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON has an agreement with Evergreen Therapeutics, Inc. to conduct Phase II clinical trial for COVID-19 drug candidate. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, ICON plc has a trailing twelve months EPS of $6.03.
PE Ratio
ICON plc has a trailing twelve months price to earnings ratio of 41.48. Meaning, the purchaser of the share is investing $41.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.02%.
4. Evertec (EVTC)
6.2% sales growth and 42.74% return on equity
EVERTEC, Inc. engages in transaction processing business in Latin America and the Caribbean. The company operates through Payment Services – Puerto Rico & Caribbean; Payment Services – Latin America; Merchant Acquiring; Business Solutions, and Corporate and Other segments. It provides merchant acquiring services, which enable point of sales and e-commerce merchants to accept and process electronic methods of payment, such as debit, credit, prepaid, and electronic benefit transfer (EBT) cards. The company also offers payment processing services that enable financial institutions and other issuers to manage, support, and facilitate the processing for credit, debit, prepaid, automated teller machines, and EBT card programs; credit and debit card processing, authorization and settlement, and fraud monitoring and control services to debit or credit issuers; and EBT services. In addition, it provides business process management solutions comprising core bank processing, network hosting and management, IT consulting, business process outsourcing, item and cash processing, and fulfillment solutions to financial institutions, and corporate and government customers. Further, the company owns and operates the ATH network, an automated teller machine and personal identification number debit networks. It manages a system of electronic payment networks that process approximately three billion transactions. The company sells and distributes its services primarily through direct sales force. It serves financial institutions, merchants, corporations, and government agencies. EVERTEC, Inc. was founded in 1988 and is headquartered in San Juan, Puerto Rico.
Earnings Per Share
As for profitability, Evertec has a trailing twelve months EPS of $3.34.
PE Ratio
Evertec has a trailing twelve months price to earnings ratio of 11.89. Meaning, the purchaser of the share is investing $11.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.74%.
